ES2323627B1 - PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. - Google Patents
PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. Download PDFInfo
- Publication number
- ES2323627B1 ES2323627B1 ES200703233A ES200703233A ES2323627B1 ES 2323627 B1 ES2323627 B1 ES 2323627B1 ES 200703233 A ES200703233 A ES 200703233A ES 200703233 A ES200703233 A ES 200703233A ES 2323627 B1 ES2323627 B1 ES 2323627B1
- Authority
- ES
- Spain
- Prior art keywords
- product
- feet
- manufacture
- procedure
- prostheses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 229920002635 polyurethane Polymers 0.000 claims abstract description 15
- 239000004814 polyurethane Substances 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 239000000654 additive Substances 0.000 claims abstract description 7
- 229920005862 polyol Polymers 0.000 claims abstract description 5
- 150000003077 polyols Chemical class 0.000 claims abstract description 5
- 239000012948 isocyanate Substances 0.000 claims abstract description 4
- 150000002513 isocyanates Chemical class 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 208000032544 Cicatrix Diseases 0.000 abstract description 2
- 230000002421 anti-septic effect Effects 0.000 abstract description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract description 2
- 239000000417 fungicide Substances 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 231100000241 scar Toxicity 0.000 abstract description 2
- 230000037387 scars Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 230000000399 orthopedic effect Effects 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- -1 bicomponent Polymers 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A43—FOOTWEAR
- A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
- A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
- A43B17/14—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined made of sponge, rubber, or plastic materials
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47B—TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE
- A47B17/00—Writing-tables
- A47B17/003—Writing-tables made of metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/01—Orthopaedic devices, e.g. splints, casts or braces
- A61F5/14—Special medical insertions for shoes for flat-feet, club-feet or the like
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Nursing (AREA)
- Manufacturing & Machinery (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
Abstract
Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados.Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear
El procedimiento se basa en que el producto para fabricar plantillas, ortesis y prótesis para pies y calzados, se obtiene a partir de la mezcla de dos componentes pre-dosificados y envasados en envases unitarios de un solo uso, predosificándose preferentemente los dos monocomponentes del poliuretano, como son el poliol y el isocianato, como materia prima utilizada normalmente para la fabricación de plantillas, ortesis y prótesis para pies y calzados. Las monodosis pre-envasadas pueden incorporar aditivos que confieren características específicas para cada tratamiento, tales como cicatrizantes, antisépticas, fungicidas, refrescantes, calmantes, estimulantes e hidratantes.The procedure is based on the product for manufacture insoles, orthotics and prostheses for feet and footwear, it obtained from the mixture of two components pre-dosed and packaged in unit packages of single use, preferably pre-dosing the two monocomponents of polyurethane, such as polyol and isocyanate, as the raw material normally used for manufacture of insoles, orthotics and prostheses for feet and footwear. Pre-packaged pods can incorporate additives that confer specific characteristics for each treatment, such as scars, antiseptics, fungicides, refreshing, soothing, stimulating and moisturizing.
Description
Procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados.Procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and footwear
La presente invención, según se expresa en el enunciado de esta memoria descriptiva, se refiere a un procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis para pies y calzados, basado en establecer una previa dosificación exacta de los componentes que intervienen en la mezcla o producto del que se obtendrá la plantilla, ortesis o prótesis, que se pretende.The present invention, as expressed in the set forth in this specification, refers to a procedure for obtaining a product for the manufacture of insoles, orthotics and prostheses for feet and shoes, based on establish an exact previous dosage of the components that they intervene in the mixture or product from which the template, brace or prosthesis, which is intended.
El objeto de la invención es provisionar al profesional de dosis unitarias con la composición específica necesaria de cada uno de los componentes del poliuretano, como producto para la materialización o conformado de la correspondiente plantilla, ortesis o prótesis.The object of the invention is to provision the unit dose professional with specific composition required of each of the polyurethane components, such as product for the materialization or shaping of the corresponding template, brace or prosthesis.
El procedimiento encuentra especial aplicación en el campo o sector de la ortopedia y de los profesionales de la podología.The procedure finds special application in the field or sector of orthopedics and professionals chiropody.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
En la fabricación de plantillas, ortesis y prótesis, a base de poliuretano, se parte del pesaje por el podólogo u otro profesional de los componentes (poliol e isocianato) cuya mezcla y correspondiente reacción de éstos permite obtener el producto de poliuretano, a partir del cual se moldea la plantilla, ortesis o prótesis.In the manufacture of templates, orthotics and prosthesis, based on polyurethane, is part of the weighing by the podiatrist or other component professional (polyol e isocyanate) whose mixture and corresponding reaction of these allows obtain the polyurethane product, from which the template, brace or prosthesis.
Los referidos componentes se comercializan en envases o botellas de volumen variable, superior al de la dosis necesaria de cada componente, de manera que el ortopeda o profesional correspondiente debe verter en el molde una cantidad definida de cada uno de dichos componentes, de acuerdo con unos parámetros técnicos definidos para cada paciente. Por lo tanto, es necesario elegir las cantidades que el ortopeda o profesional considera como más adecuadas para componer la formulación de cada una de las plantillas, ortesis o prótesis a conformar.The referred components are marketed in containers or bottles of variable volume, higher than the dose necessary for each component, so that the orthopedic or corresponding professional must pour an amount into the mold defined of each one of said components, according to some technical parameters defined for each patient. Therefore it is necessary to choose the amounts that the orthopedic or professional considered as more appropriate to compose the formulation of each one of the templates, braces or prostheses to be shaped.
Esto supone que es responsabilidad del ortopeda o profesional acertar con la dosis, lo que en ocasiones no es fácil, llevando consigo que a veces los resultados no sean los deseados, ya que con variaciones de tan sólo el 2-3% en la dosificación de alguno de dichos componentes, se pueda obtener un producto de efectos negativos, y con ello una plantilla, ortesis o prótesis, que carece de efectividad.This assumes that it is the responsibility of the orthopedic or professional get the dose right, which sometimes is not easy, taking with it that sometimes the results are not the desired, since with variations of only 2-3% in the dosage of any of these components, it can be obtain a product of negative effects, and with it a template, orthosis or prosthesis, which lacks effectiveness.
Evidentemente, el fabricante de poliuretano aconseja o indica los pesos que de ambos componentes se deben adicionar para formar la mezcla y, como se decía con anterioridad, mínimas variaciones implican cambios sustanciales de las propiedades del poliuretano, pues a pesar de que el profesional selecciona cuidadosamente los tipos de material a utilizar para corregir la patología a tratar, y teniendo en cuenta que la plantilla es un elemento fundamental para el tratamiento o corrección de una anomalía del pie, más allá del confort, un inadecuado control puede provocar un mal tratamiento.Obviously, the manufacturer of polyurethane advises or indicates the weights of both components due add to form the mixture and, as previously stated, minimal variations imply substantial changes in properties of polyurethane, because although the professional selects carefully the types of material to use to correct the pathology to be treated, and considering that the template is a fundamental element for the treatment or correction of a foot abnormality, beyond comfort, inadequate control may cause a bad treatment.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
El procedimiento objeto de la invención se basa en intentar evitar que por una inadecuada manipulación en la pesada de los componentes, las propiedades del producto obtenido dejen de tener su función.The process object of the invention is based in trying to avoid that due to improper handling in the heavy components, the properties of the product obtained Stop having your function.
Más concretamente, el procedimiento de obtención de un producto para la fabricación de plantillas, ortesis y prótesis del tipo de las que se obtienen a partir de una mezcla de poliol e isocianato, como componentes del poliuretano, presenta la particularidad de que dichos dos componentes se mezclan a partir de cantidades dosificadas unitariamente en envases de un solo uso; es decir, que los componentes son pre-dosificados y envasados independientemente en envases unitarios.More specifically, the procedure for obtaining of a product for the manufacture of templates, orthotics and prostheses of the type obtained from a mixture of polyol and isocyanate, as components of polyurethane, presents the particularity that said two components are mixed from unit dose quantities in single-use containers; is say that the components are pre-dosed and packaged independently in unit packages.
Por otra parte, y como otra característica del procedimiento, cabe destacar el hecho de que, al menos, uno de esos componentes incorpora diferentes aditivos que confieren características específicas para cada tratamiento.On the other hand, and as another characteristic of procedure, it should be noted that at least one of those components incorporates different additives that confer specific characteristics for each treatment.
Asimismo, es característico el hecho de que cada uno de los envases contenedores de los componentes, presenta una codificación con un color diferente para poder distinguir el tipo de aditivo que incorpora, lo cual indicará al profesional el componente a utilizar de acuerdo con el tipo de tratamiento a prescribir, y por lo tanto el tipo de plantilla a fabricar.Likewise, the fact that each one of the container containers of the components, presents a coding with a different color to distinguish the type of additive that incorporates, which will indicate to the professional the component to be used according to the type of treatment to prescribe, and therefore the type of template to be manufactured.
En la obtención del producto se puede utilizar poliuretano monocomponente, bicomponente, poliéster, poliéter, e incluso con otros polímeros donde la dosificación sea fundamental y se establezcan dosis exactas envasadas en envases independientes y de un solo uso.In obtaining the product can be used monocomponent polyurethane, bicomponent, polyester, polyether, e even with other polymers where the dosage is essential and exact doses packaged in separate containers are established and single use only.
\newpage\ newpage
En cuanto a los aditivos que se pueden incorporar en las monodosis pre-envasadas y dosificadas, pueden citarse lo siguientes:As for the additives that can be incorporate in pre-packaged pods and dosed, the following may be cited:
- --
- Cicatrizantes: como aceite esencial de lavanda, dirigidas a los pies diabéticos y/o sensibles.Scars: as an essential oil of Lavender, aimed at diabetic and / or sensitive feet.
- --
- Antisépticos y fungicidas: como el aceite esencial del árbol de té, para la prevención de infecciones.Antiseptics and fungicides: such as essential oil of the tea tree, for the prevention of infections
- --
- Calmantes y relajantes: como el aceite esencial de salvia, pensado para el calzado deportivo y de estar por casa.Soothing and relaxing: like oil essential sage, designed for sports shoes and to be at home.
- --
- Estimulantes: para activar la circulación.Stimulants: to activate the circulation.
- --
- Hidratantes: como la urea, el panthenol y bisabolol, la glicerina y aceites naturales hidratantes dirigidas a atenuar la sequedad y/o grietas de los pies.Moisturizers: such as urea, panthenol and bisabolol, glycerin and natural moisturizing oils aimed at attenuating dryness and / or cracks of the feet.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Las plantillas, ortesis y prótesis, que se pueden fabricar con el producto obtenido de acuerdo con el procedimiento de la invención, pueden ser:The insoles, braces and prostheses, which are can be manufactured with the product obtained in accordance with the Process of the invention, can be:
- --
- Plantillas, ortesis y prótesis, realizadas con sistemas de monodosis de poliuretano bicomponente.Insoles, orthotics and prostheses, made with single-dose polyurethane systems bicomponent
- --
- Plantillas, ortesis y prótesis, realizadas con sistema de monodosis de poliuretano bicomponente con propiedades cosméticas, teniendo en cuenta que los aditivos serán incorporados preferentemente dentro del componente de poliol.Insoles, orthotics and prostheses, made with two-component polyurethane single-dose system with cosmetic properties, taking into account that the additives will preferably be incorporated into the component of polyol
- --
- Plantillas, ortesis y prótesis, realizadas con otros polímeros con monodosis o no.Insoles, orthotics and prostheses, made with other polymers with single dose or not.
- --
- Formas realizadas con sistema de monodosis de poliuretano bicomponente.Shapes made with polyurethane single dose system bicomponent
- --
- Desmoldeante para el secado de horma.Release agent for drying last.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Finalmente, en cuanto a las ventajas derivadas del procedimiento de la invención, pueden citarse como más importantes las siguientes:Finally, regarding the advantages derived of the process of the invention, can be cited as more important the following:
1.- Se asegura una dosificación exacta de poliuretano reactivo, garantizando con ello propiedades del producto final.1.- An exact dosage of reactive polyurethane, thereby guaranteeing properties of the Final product.
2.- No requiere efectuar pesadas de los componentes, evitando posibles errores en la manipulación.2.- It does not require weighing of the components, avoiding possible handling errors.
3.- Óptimas propiedades físicas referentes a la viscosidad y similares.3.- Optimal physical properties referring to the viscosity and the like.
4.- Facilidad, rapidez y limpieza en el manejo de los componentes, al estar contenidos en envases monodosis.4.- Ease, speed and cleanliness in handling of the components, being contained in single-dose containers.
5.- Se evita el almacenamiento de productos químicos abiertos, por lo que se protegen las personas expuestas.5.- The storage of products is avoided open chemicals, so people protect themselves exposed.
6.- Resistencia a la degradación de los componentes por la acción del ambiente, ya que el envase unitario que los contiene se abre en el momento de ser utilizado.6.- Resistance to degradation of components by the action of the environment, since the unit packaging which contains them opens at the time of use.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200703233A ES2323627B1 (en) | 2007-12-05 | 2007-12-05 | PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200703233A ES2323627B1 (en) | 2007-12-05 | 2007-12-05 | PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2323627A1 ES2323627A1 (en) | 2009-07-21 |
| ES2323627B1 true ES2323627B1 (en) | 2010-05-11 |
Family
ID=40852596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES200703233A Expired - Fee Related ES2323627B1 (en) | 2007-12-05 | 2007-12-05 | PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2323627B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3103699B1 (en) * | 2019-11-29 | 2021-12-10 | Thuasne | Device for treating at least one area of the body comprising an orthosis and at least one flexible insert having at least one mechanical function comprising a silicone polymer matrix comprising at least one active principle. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3027186A1 (en) * | 1980-07-18 | 1982-02-11 | Bayer Ag, 5090 Leverkusen | ORTHOPEDIC WALKING CLOTHES FOR SUPPORTING ON THE FOOT |
| US4524102A (en) * | 1984-02-15 | 1985-06-18 | Fritz Hostettler | Microcellular polyurethane foams having integral skin |
| US5088484A (en) * | 1990-10-05 | 1992-02-18 | Carolina Narrow Fabric Company | Orthopedic casting bandage |
| DE19812442C1 (en) * | 1998-03-21 | 1999-10-28 | B & F Formulier Und Abfuell Gm | Double chamber cartridge to create a 2-component polyurethane foam |
| DE10084903B4 (en) * | 1999-08-19 | 2009-08-13 | Asahi Kasei Kabushiki Kaisha | polyether |
| EP1801029A1 (en) * | 2005-12-23 | 2007-06-27 | Bafotec GmbH | Plastic pouch having two compartments |
-
2007
- 2007-12-05 ES ES200703233A patent/ES2323627B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2323627A1 (en) | 2009-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657715A (en) | Drug combination with function of improving sleep | |
| WO2013108918A1 (en) | Pack cosmetic accommodating article, cosmetic pack, and manufacturing method for pack cosmetic | |
| ES2323627B1 (en) | PROCEDURE FOR OBTAINING A PRODUCT FOR THE MANUFACTURE OF TILLAS PLAN, ORTHESIS AND PROTESIS FOR FEET AND SHOES. | |
| CN102112075A (en) | Articles providing refreshing or warming effect to users | |
| US9943434B2 (en) | Viscoelastic element | |
| ES2718909T3 (en) | Method of treatment of corn kernels intended to obtain popcorn by means of microwave devices and product obtained | |
| JP2013234280A (en) | Method for producing hydrogel | |
| CN105707569A (en) | Chewing tablet capable of enhancing bone mineral density and supplementing vitamin D as well as production method thereof | |
| KR101984953B1 (en) | A manufacturing method of functional foods | |
| KR20160117080A (en) | Soluble mask sheet, mask pack for cosmetics, and packaging kit comprising the same | |
| CN205698175U (en) | Set waterproof and breathable multi-functional ankle joint brace | |
| CN106264893A (en) | Temp. controllable absorbent article | |
| WO2013115879A1 (en) | Oil resistant polymer devices and kits for treating fungal infected nails and methods of use thereof | |
| Lee | Case reports on 70 Tic disorder cases managed with functional cerebrospinal therapy (FCST) | |
| CN106619946A (en) | Traditional Chinese medicine formula for treating tinea pedis | |
| CN108185056A (en) | A kind of health-care medical health preserving tea and preparation method thereof | |
| KR100895109B1 (en) | Band for softening of wrinkles | |
| CN201563718U (en) | Toe-combining balance-improving fitness shoe | |
| KR20230099809A (en) | Supplements for the treatment of foot disorders | |
| Day | Healthy Living | |
| RU95472U1 (en) | HEATING SHOES | |
| CN206744702U (en) | The spontaneous electric heating insole of far infrared and footwear | |
| CN106306779A (en) | Rose fragrant congee | |
| RU162531U1 (en) | PERSONALIZABLE ANATOMIC SHOES | |
| CN206137342U (en) | Health care shoes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 20090721 Kind code of ref document: A1 |
|
| FG2A | Definitive protection |
Ref document number: 2323627B1 Country of ref document: ES |
|
| PC2A | Transfer of patent |
Owner name: BIOMECH CONSULTING, S.L. Effective date: 20160418 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20211119 |